OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review
Qilong Nie, Mingyang Li, Caiyang Huang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Qilong Nie, Mingyang Li, Caiyang Huang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Showing 12 citing articles:
NAFLD in the 21st Century: Current Knowledge Regarding Its Pathogenesis, Diagnosis and Therapeutics
Dimitris Kounatidis, Natalia G. Vallianou, Eleni Geladari, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 826-826
Open Access | Times Cited: 11
Dimitris Kounatidis, Natalia G. Vallianou, Eleni Geladari, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 826-826
Open Access | Times Cited: 11
Altered Mitochondrial Function in MASLD: Key Features and Promising Therapeutic Approaches
Tatjana Radosavljević, Milica Branković, Janko Samardžić, et al.
Antioxidants (2024) Vol. 13, Iss. 8, pp. 906-906
Open Access | Times Cited: 9
Tatjana Radosavljević, Milica Branković, Janko Samardžić, et al.
Antioxidants (2024) Vol. 13, Iss. 8, pp. 906-906
Open Access | Times Cited: 9
Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease
Daniela Ciobârcă, Adriana Florinela Cătoi, Laura Gavrilaș, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 279-279
Open Access
Daniela Ciobârcă, Adriana Florinela Cătoi, Laura Gavrilaș, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 279-279
Open Access
Enhancing the Therapeutic Efficacy of Berberine and Quercetin Through Salt Formulation for Liver Fibrosis Treatment
Yangyang Cheng, Haoyang Yu, Si-Tong Yang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2193-2193
Open Access
Yangyang Cheng, Haoyang Yu, Si-Tong Yang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2193-2193
Open Access
Pharmacological landscape of endoplasmic reticulum stress: uncovering therapeutic avenues for metabolic diseases
Ghallab Alotaibi, Abdullah Alkhammash
European Journal of Pharmacology (2025), pp. 177509-177509
Closed Access
Ghallab Alotaibi, Abdullah Alkhammash
European Journal of Pharmacology (2025), pp. 177509-177509
Closed Access
From adiposity to steatosis: metabolic dysfunction-associated steatotic liver disease, a hepatic expression of metabolic syndrome – current insights and future directions
Bruno Basil, B. Myke-Mbata, Onyinye Ezinne Eze, et al.
Clinical Diabetes and Endocrinology (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 2
Bruno Basil, B. Myke-Mbata, Onyinye Ezinne Eze, et al.
Clinical Diabetes and Endocrinology (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 2
Unlocking Cholesterol Metabolism in Metabolic-Associated Steatotic Liver Disease: Molecular Targets and Natural Product Interventions
X. Li, Meng Li
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1073-1073
Open Access | Times Cited: 1
X. Li, Meng Li
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1073-1073
Open Access | Times Cited: 1
Understanding Macrophage Complexity in Metabolic Dysfunction-Associated Steatotic Liver Disease: Transitioning from the M1/M2 Paradigm to Spatial Dynamics
Forkan Ahamed, Natalie Eppler, Elizabeth Jones, et al.
Livers (2024) Vol. 4, Iss. 3, pp. 455-478
Open Access | Times Cited: 1
Forkan Ahamed, Natalie Eppler, Elizabeth Jones, et al.
Livers (2024) Vol. 4, Iss. 3, pp. 455-478
Open Access | Times Cited: 1
Extraction and recovery of bioactive alkaloids from Phellodendron amurense Rupr. Using ultrasound-assisted green solvents and macroporous resins
Nhan Trong Le, Trinh Thuc Le, Đức Việt Hồ, et al.
Sustainable Chemistry and Pharmacy (2024) Vol. 42, pp. 101809-101809
Closed Access | Times Cited: 1
Nhan Trong Le, Trinh Thuc Le, Đức Việt Hồ, et al.
Sustainable Chemistry and Pharmacy (2024) Vol. 42, pp. 101809-101809
Closed Access | Times Cited: 1
Study the Physiological and Biochemical Effects of Berberine Extract on Nonalcoholic Fatty Liver Disease (NAFLD) in Male Rabbits
H.H.K. Al-Shukri, Areej GH Al-Charak, Rusul Saleem, et al.
South Asian Research Journal of Pharmaceutical Sciences (2024) Vol. 6, Iss. 03, pp. 44-47
Open Access
H.H.K. Al-Shukri, Areej GH Al-Charak, Rusul Saleem, et al.
South Asian Research Journal of Pharmaceutical Sciences (2024) Vol. 6, Iss. 03, pp. 44-47
Open Access
Multicomponent phytopharmaceutical Dipana for the treatment of hepatobiliary disorders. A review
V. A. Prikhodko, S. V. Okovityi
Consilium Medicum (2024) Vol. 26, Iss. 5, pp. 309-316
Open Access
V. A. Prikhodko, S. V. Okovityi
Consilium Medicum (2024) Vol. 26, Iss. 5, pp. 309-316
Open Access
A critical evaluation of berberine in NAFLD management: recommendations for improved research methodology
Yi Qiang, Xinting Ouyang, Weijian Zhu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
Yi Qiang, Xinting Ouyang, Weijian Zhu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
Renoprotective Effect of Berberine in Cisplatin-Induced Acute Kidney Injury: Role of Klotho and the AMPK/mTOR/ULK1/Beclin-1 Pathway
Tarek Salah, Mostafa A. Rabie, Nesrine S. El Sayed
Food and Chemical Toxicology (2024), pp. 115179-115179
Closed Access
Tarek Salah, Mostafa A. Rabie, Nesrine S. El Sayed
Food and Chemical Toxicology (2024), pp. 115179-115179
Closed Access
